Profiles

Keywords
Last Name
Institution

Connection

Search Results to Kerstin Stenson

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Stenson, Kerstin

Item TypeName
Concept Antineoplastic Combined Chemotherapy Protocols
Concept Induction Chemotherapy
Concept Chemotherapy, Adjuvant
Academic Article Therapeutic options for laryngeal cancer.
Academic Article Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Academic Article Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Academic Article Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
Academic Article Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer.
Academic Article Planned post-chemoradiation neck dissection: significance of radiation dose.
Academic Article Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
Academic Article High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
Academic Article A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.
Academic Article Aspiration in chemoradiated patients with head and neck cancer.
Academic Article Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
Academic Article Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Academic Article Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
Academic Article Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
Academic Article Neck dissection planning based on postchemoradiation computed tomography in patients with head and neck cancer.
Academic Article Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.
Academic Article Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
Academic Article Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.
Academic Article Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.
Academic Article Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Academic Article Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.
Academic Article Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.
Academic Article DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.
Academic Article Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
Academic Article Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
Academic Article Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Academic Article The role of paclitaxel in the treatment of head and neck cancer.
Academic Article Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
Academic Article Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.
Academic Article Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
Academic Article Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination.
Academic Article Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
Academic Article Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Academic Article A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer.
Academic Article Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
Academic Article Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
Academic Article Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary.
Academic Article Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.
Academic Article Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.
Academic Article Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.
Academic Article A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
Academic Article Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
Academic Article A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFeradeā„¢ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
Academic Article Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.
Academic Article Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer.

Search Criteria
  • Drug Therapy